Earnings Feed
Start Free
CorMedix Inc.·4

Jan 27, 9:30 PM ET

Kaplan Myron 4

4 · CorMedix Inc. · Filed Jan 27, 2026

Research Summary

AI-generated summary of this filing

Updated

CorMedix (CRMD) Director Myron Kaplan Receives 30,453 RSUs

What Happened

  • Myron Kaplan, a director of CorMedix Inc. (CRMD), received an award of 30,453 restricted stock units (RSUs) on January 26, 2026. The filing reports the RSUs were granted at $0.00 (no purchase price), so the grant value at issuance is listed as $0.

Key Details

  • Transaction date: 2026-01-26 (reported on Form 4 filed 2026-01-27)
  • Transaction type/code: Award/Grant (A)
  • Shares/units granted: 30,453 RSUs; grant price shown as $0.00
  • Vesting: RSUs vest in full on January 26, 2027, subject to continued service (footnote F1)
  • Beneficial ownership: Reporting person disclaims beneficial ownership of these securities (footnote F2)
  • Shares owned after transaction: Not specified in the filing
  • Filing timeliness: Filed the next day (appears timely); Exhibit 24.1 (Power of Attorney) included in the filing

Context

  • RSUs represent a right to receive common stock upon vesting and do not involve an immediate cash purchase or sale. Because these units vest in a year (subject to continued service), they do not reflect an immediate change in market holdings and are a common form of compensation for directors. The F2 disclaimer is standard language and does not change the grant terms.

Insider Transaction Report

Form 4
Period: 2026-01-26
CorMedix Inc.CRMD
Kaplan Myron
Director
Transactions
  • Award

    Common Stock

    [F1]
    2026-01-26+30,453→ 231,487 total
Holdings

  • Common Stock

    [F2]
    (indirect: By Spouse)
    20,000

  • Common Stock

    [F2]
    (indirect: By Spouse)
    10,000
Footnotes (2)
  • [F1]These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date.
  • [F2]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
Signature
/s/ Beth Zelnick Kaufman, attorney-in-fact|2026-01-27

Documents

2 files